PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
46.94
+1.86 (4.13%)
Apr 15, 2025, 4:00 PM EDT - Market closed
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$859,191
Profits / Employee
-$386,896
Market Cap
3.70B
Employees Chart
Employees History
PTCT News
- 18 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 18 days ago - PTC Therapeutics Shares Fall After EU Drops Translarna Authorization - Market Watch
- 18 days ago - PTC Therapeutics says European Commission will remove muscle disorder drug - Reuters
- 18 days ago - PTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren) in Europe - PRNewsWire
- 26 days ago - PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies - PRNewsWire
- 5 weeks ago - PTC Therapeutics: Upside In Rare Disease Innovation - Seeking Alpha
- 6 weeks ago - PTC Therapeutics, Inc. (PTCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire